Evaluation of self-monitoring of blood pressure in the PERHIT study and the impact on glomerular function

被引:0
作者
Ekholm, Mikael [1 ,2 ]
Andersson, Ulrika [3 ]
Nilsson, Peter M. [4 ]
Kjellgren, Karin [5 ,6 ]
Midlov, Patrik [3 ]
机构
[1] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Stockholm, Sweden
[2] Wetterhalsan Primary Hlth Care Ctr, Jonkoping, Sweden
[3] Lund Univ, Ctr Primary Hlth Care Res, Dept Clin Sci Malmo, Malmo, Sweden
[4] Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden
[5] Univ Gothenburg, Sahlgrenska Acad, Ctr Person Centred Care GPCC, Gothenburg, Sweden
[6] Linkoping Univ, Dept Hlth Med & Caring Sci, Linkoping, Sweden
基金
瑞典研究理事会; 英国医学研究理事会;
关键词
Blood pressure; hypertension; information technology; renal function; self-monitoring blood pressure; CHRONIC KIDNEY-DISEASE; PULSE PRESSURE; RENAL DYSFUNCTION; LIFE-STYLE; FOLLOW-UP; RISK; HYPERTENSION; HYPERFILTRATION; PREVENTION; MANAGEMENT;
D O I
10.1080/08037051.2024.2399565
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Although intensive blood pressure (BP) control has not been shown to slow the progression of chronic kidney disease (CKD), intensive BP control has been shown to reduce the risk for adverse cardiovascular outcomes in the CKD population. The aim of this post-hoc study was to study the interplay between a self-monitoring BP system and glomerular function. Methods: In all, 949 participants with hypertension underwent visits at baseline, after eight weeks and 12 months. Half of the participants received a BP monitor and installed a program on their mobile phone. During eight weeks, they measured daily and reported their BP values. Results: Within the intervention group, BP and systolic BP (SBP) decreased from baseline to eight weeks and 12 months (p < .001). Pulse pressure (PP) and mean arterial blood pressure (MAP) decreased from baseline to eight weeks (p = .021 and p = .004) vs 12 months (p = .035 and p = .008). Within the control group, a decrease was observed from baseline to 12 months for SBP, diastolic BP (DBP) and PP (p = .025, p = .023 and p = .036). In the intervention group, we observed an association between a decrease in SBP, DBP, PP and MAP and a decrease in eGFR (estimated glomerular filtration rate), (p < .001, p < .001, p = .013 and p < .001). In the control group, similar results were observed for PP only (p = .027). Within the intervention group, eGFR decreased (p < .001) but within the control group, the decrease was non-significant (p = .051). Conclusion: We observed an association between a decrease in all BP components and eGFR decline within the normal range in the intervention group but not in the controls.
引用
收藏
页数:12
相关论文
共 52 条
[1]   PERson-centredness in Hypertension management using Information Technology: a randomized controlled trial in primary care [J].
Andersson, Ulrika ;
Nilsson, Peter M. ;
Kjellgren, Karin ;
Hoffmann, Mikael ;
Wennersten, Andre ;
Midloev, Patrik .
JOURNAL OF HYPERTENSION, 2023, 41 (02) :246-253
[2]   Patients and Professionals as Partners in Hypertension Care: Qualitative Substudy of a Randomized Controlled Trial Using an Interactive Web-Based System Via Mobile Phone [J].
Andersson, Ulrika ;
Bengtsson, Ulrika ;
Ranerup, Agneta ;
Midlov, Patrik ;
Kjellgren, Karin .
JOURNAL OF MEDICAL INTERNET RESEARCH, 2021, 23 (06)
[3]   Association Between Systolic and Diastolic Blood Pressure Variability and the Risk of End-Stage Renal Disease [J].
Bae, Eun Hui ;
Lim, Sang Yup ;
Han, Kyung-Do ;
Oh, Tae Ryom ;
Choi, Hong Sang ;
Kim, Chang Seong ;
Ma, Seong Kwon ;
Kim, Soo Wan .
HYPERTENSION, 2019, 74 (04) :880-887
[4]   Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine - Is this a cause for concern? [J].
Bakris, GL ;
Weir, MR .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (05) :685-693
[5]   Renal microvascular dysfunction, hypertension and CKD progression [J].
Bidani, Anil K. ;
Polichnowski, Aaron J. ;
Loutzenhiser, Rodger ;
Griffin, Karen A. .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2013, 22 (01) :1-9
[6]   Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients [J].
Blacher, J ;
Staessen, JA ;
Girerd, X ;
Gasowski, J ;
Thijs, L ;
Liu, LS ;
Wang, JG ;
Fagard, RH ;
Safar, ME .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (08) :1085-1089
[7]   Initial Estimated Glomerular Filtration Rate Decline and Long-Term Renal Function During Intensive Antihypertensive Therapy A Post Hoc Analysis of the SPRINT and ACCORD-BP Randomized Controlled Trials [J].
Collard, Didier ;
Brouwer, Tom F. ;
Engberink, Rik H. G. ;
Zwinderman, Aeilko H. ;
Vogt, Liffert ;
van den Born, Bert-Jan H. .
HYPERTENSION, 2020, 75 (05) :1205-1212
[8]   Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus [J].
Cushman, William C. ;
Evans, Gregory W. ;
Byington, Robert P. ;
Goff, David C., Jr. ;
Grimm, Richard H., Jr. ;
Cutler, Jeffrey A. ;
Simons-Morton, Denise G. ;
Basile, Jan N. ;
Corson, Marshall A. ;
Probstfield, Jeffrey L. ;
Katz, Lois ;
Peterson, Kevin A. ;
Friedewald, William T. ;
Buse, John B. ;
Bigger, J. Thomas ;
Gerstein, Hertzel C. ;
Ismail-Beigi, Faramarz .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (17) :1575-1585
[9]   Nephron Hypertrophy and Glomerulosclerosis and Their Association with Kidney Function and Risk Factors among Living Kidney Donors [J].
Elsherbiny, Hisham E. ;
Alexander, Mariam P. ;
Kremers, Walter K. ;
Park, Walter D. ;
Poggio, Emilio D. ;
Prieto, Mike ;
Lieske, John C. ;
Rule, Andrew D. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 9 (11) :1892-1902
[10]   Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis [J].
Ettehad, Dena ;
Emdin, Connor A. ;
Kiran, Amit ;
Anderson, Simon G. ;
Callender, Thomas ;
Emberson, Jonathan ;
Chalmers, John ;
Rodgers, Anthony ;
Rahimi, Kazem .
LANCET, 2016, 387 (10022) :957-967